Genetic Ablation of Bcl-x Attenuates Invasiveness without Affecting Apoptosis or Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Cancer

• Jeffrey H. Hager ,

  Contributed equally to this work with: Jeffrey H. Hager, Danielle B. Ulanet

  Current address: Apoptos Inc., San Diego, California, United State of America

  Affiliation Diabetes and Hellen Diller Family Comprehensive Cancer Centers, Department of Biochemistry & Biophysics, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Danielle B. Ulanet ,

  Contributed equally to this work with: Jeffrey H. Hager, Danielle B. Ulanet

  Affiliation Diabetes and Hellen Diller Family Comprehensive Cancer Centers, Department of Biochemistry & Biophysics, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Lothar Hennighausen,

  Affiliation Laboratory of Genetics and Physiology, The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Douglas Hanahan

  * E-mail: dh@biochem.ucsf.edu

  Affiliation Diabetes and Hellen Diller Family Comprehensive Cancer Centers, Department of Biochemistry & Biophysics, University of California San Francisco, San Francisco, California, United States of America

  ⨯